Müller-Brand, Jan

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 11.

Journal Article

Umlauft, Maria; Radojewski, Piotr; Spanjol, Petar Marko; Dumont, Rebecca; Marincek, Nicolas; Kollár, Attila; Brunner, Philippe; Beyersmann, Jan; Müller-Brand, Jan; Maecke, Helmut R; Laimer, Markus; Walter, Martin Alexander (2017). Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic Issues. Journal of nuclear medicine, 58(9), p. 1532. Society of Nuclear Medicine 10.2967/jnumed.117.190660

Brunner, Philippe; Jörg, Ann-Catherine; Glatz, Katharina; Bubendorf, Lukas; Radojewski, Piotr; Umlauft, Maria; Marincek, Nicolas; Spanjol, Petar Marko; Krause, Thomas Michael; Dumont, Rebecca A; Maecke, Helmut R; Müller-Brand, Jan; Briel, Matthias; Schmitt, Anja; Perren, Aurel; Walter, Martin Alexander (2017). The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors. European journal of nuclear medicine and molecular imaging, 44(3), pp. 468-475. Springer 10.1007/s00259-016-3486-2

Radojewski, Piotr; Dumont, Rebecca A; Marincek, Nicolas; Brunner, Philippe; Müller-Brand, Jan; Maecke, Helmut R; Briel, Matthias; Walter, Martin Alexander (2016). Reply: Somatostatin Receptor-Targeted Radiopeptide Therapy in Patients with Progressive Unresectable Meningioma. Journal of nuclear medicine, 57(10), pp. 1657-1658. Society of Nuclear Medicine 10.2967/jnumed.116.178145

Radojewski, Piotr; Dumont, Rebecca; Marincek, Nicolas; Brunner, Philippe; Mäcke, Helmut R; Müller-Brand, Jan; Briel, Matthias; Walter, Martin Alexander (2015). Towards tailored radiopeptide therapy. European journal of nuclear medicine and molecular imaging, 42(8), pp. 1231-1237. Springer 10.1007/s00259-015-3030-9

Dumont, Rebecca A; Seiler, Daniela; Marincek, Nicolas; Brunner, Philippe; Radojewski, Piotr; Rochlitz, Christoph; Müller-Brand, Jan; Maecke, Helmut R; Briel, Matthias; Walter, Martin Alexander (2015). Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma. American journal of nuclear medicine and molecular imaging, 5(1), pp. 46-55.

Marincek, Nicolas; Jörg, Ann-Catherine; Brunner, Philippe; Schindler, Christian; Koller, Michael T.; Rochlitz, Christoph; Müller-Brand, Jan; Maecke, Helmut R.; Briel, Matthias; Walter, Martin Alexander (2013). Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study. Journal of translational medicine, 11, p. 17. BioMed Central 10.1186/1479-5876-11-17

Villard, Linda; Romer, Anna; Marincek, Nicolas; Brunner, Philippe; Koller, Michael T; Schindler, Christian; Ng, Quinn K T; Mäcke, Helmut R; Müller-Brand, Jan; Rochlitz, Christoph; Briel, Matthias; Walter, Martin A (2012). Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers. Journal of clinical oncology, 30(10), pp. 1100-6. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2011.37.2151

Fuchs, Martin; Briel, Matthias; Daikeler, Thomas; Walker, Ulrich A; Rasch, Helmut; Berg, Scott; Ng, Quinn K T; Raatz, Heike; Jayne, David; Kötter, Ina; Blockmans, Daniel; Cid, Maria C; Prieto-González, Sergio; Lamprecht, Peter; Salvarani, Carlo; Karageorgaki, Zaharenia; Watts, Richard; Luqmani, Raashid; Müller-Brand, Jan; Tyndall, Alan; ... (2012). The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis. European journal of nuclear medicine and molecular imaging, 39(2), pp. 344-53. Berlin: Springer 10.1007/s00259-011-1967-x

Imhof, Anna; Brunner, Philippe; Marincek, Nicolas; Briel, Matthias; Schindler, Christian; Rasch, Helmut; Mäcke, Helmut R; Rochlitz, Christoph; Müller-Brand, Jan; Walter, Martin A (2011). Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers. Journal of clinical oncology, 29(17), pp. 2416-23. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.33.7873

Walter, Martin A; Meier, Christian; Radimerski, Tanja; Iten, Fabienne; Kränzlin, Marius; Müller-Brand, Jan; de Groot, Jan Willem B; Kema, Ido P; Links, Thera P; Müller, Beat (2010). Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer, 116(1), pp. 31-40. New York, N.Y.: John Wiley & Sons 10.1002/cncr.24738

Good, Stephan; Walter, Martin A; Waser, Beatrice; Wang, Xuejuan; Müller-Brand, Jan; Béhé, Martin P; Reubi, Jean-Claude; Maecke, Helmut R (2008). Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours. European journal of nuclear medicine and molecular imaging, 35(10), pp. 1868-77. Berlin: Springer 10.1007/s00259-008-0803-4

This list was generated on Mon Apr 29 22:24:19 2024 CEST.
Provide Feedback